BELDEN INC. Stock Compensation Disclosure
| Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (In thousands) | |||||||||||||||||
| Total share-based compensation cost | $ | 30,015 | $ | 27,532 | $ | 21,024 | |||||||||||
| Income tax benefit | 7,144 | 6,553 | 5,004 | ||||||||||||||
| Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (In thousands, except weighted average fair value and assumptions) | |||||||||||||||||
| Weighted-average fair value of SARs granted | n/a | n/a | $ | 39.44 | |||||||||||||
| Total intrinsic value of SARs exercised | 4,509 | 5,696 | 12,229 | ||||||||||||||
| Tax expense (benefit) from SARs exercised | (477) | (420) | 660 | ||||||||||||||
| Weighted-average fair value of restricted stock units granted | 120.25 | 89.98 | 95.32 | ||||||||||||||
| Total fair value of restricted stock units vested | 29,688 | 14,031 | 19,821 | ||||||||||||||
| Expected volatility | 37.64 | % | 38.88 | % | 43.45 | % | |||||||||||
| Expected term (in years) | 2.8 | 2.9 | 5.7 | ||||||||||||||
| Risk-free rate | 3.98 | % | 4.40 | % | 4.26 | % | |||||||||||
| Dividend yield | 0.18 | % | 0.25 | % | 0.23 | % | |||||||||||
| Stock Appreciation Rights | Restricted Stock Units | ||||||||||||||||||||||||||||||||||
| Number | Weighted- Average Exercise Price | Weighted- Average Remaining Contractual Term | Aggregate Intrinsic Value | Number | Weighted- Average Grant-Date Fair Value | ||||||||||||||||||||||||||||||
| (In thousands, except exercise prices, fair values, and contractual terms) | |||||||||||||||||||||||||||||||||||
| Outstanding at January 1, 2025 | 263 | $ | 66.29 | 6.5 | $ | 12,199 | 891 | $ | 83.35 | ||||||||||||||||||||||||||
| Granted | — | — | 441 | 120.25 | |||||||||||||||||||||||||||||||
| Exercised or converted | (85) | 63.93 | (392) | 75.74 | |||||||||||||||||||||||||||||||
| Forfeited or expired | (2) | 82.77 | (54) | 100.54 | |||||||||||||||||||||||||||||||
| Outstanding at December 31, 2025 | 176 | $ | 67.16 | 5.9 | $ | 8,706 | 886 | $ | 99.60 | ||||||||||||||||||||||||||
| Exercisable or convertible at December 31, 2025 | 145 | $ | 63.16 | 5.6 | $ | 7,745 | |||||||||||||||||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 17, 2026 | Showing above |
| 2024 | Feb 13, 2025 | |
| 2023 | Feb 13, 2024 | |
| 2022 | Feb 24, 2023 | |
| 2021 | Feb 15, 2022 | |
| 2020 | Feb 16, 2021 | |
| 2019 | Feb 11, 2020 | |
| 2018 | Feb 20, 2019 | |
| 2017 | Feb 13, 2018 | |
| 2016 | Feb 17, 2017 | |
| 2015 | Feb 25, 2016 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.